vTv Therapeutics (VTVT) Financials: Revenue & Earnings

VTVT price $25.61 -0.10 -0.41%

Ticker
VTVT
Price
$25.61
Change
-0.10 -0.41%
Market cap ?
$101.28M
Beta ?
0.28
Sector
Healthcare
Industry
Biotechnology

Fair value

VTVT fair value Not meaningful. Price $25.61.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare VTVT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-1.07—333.33K
2026-08-06-1.05-0.97—333.33K
2026-05-131.650.3436.84M20.00M
2026-03-10-0.58-0.98——
2025-11-06-1.08-0.97——
2025-08-12-0.92-0.85——
2025-05-15-0.77-0.73——
2025-03-20-0.55-0.8717.00K—
2024-11-12-0.88-3.60——
2024-08-08-0.81-3.20——
2024-05-09-1.17-3.201.00M—
2024-03-13-1.67-2.80-9.00K—
2023-11-09-3.20-3.20——
2023-08-11-2.80-0.079.00K—
2023-05-11-2.40-3.20——
2023-03-06-2.40-2.409.00K—
2022-11-10-2.00-2.00—250.00K
2022-08-15-1.60-4.009.00K—
2022-05-12-4.00-3.202.00M—
2022-03-29-3.20-3.209.00K500.00K
2021-11-09-0.80-2.803.00M1.30M
2021-08-04-0.40-2.809.00K9.00K
2021-05-05-3.60-2.40987.00K800.00K
2021-02-240.80-2.406.40M3.30M
2020-11-05-1.20-4.407.00K21.00K
2020-08-03-3.20-4.00—10.29K
2020-05-07-4.40-4.008.00K—
2020-02-20-4.40-4.007.00K4.85K
2019-10-30-4.00-4.408.00K6.77K
2019-07-31-3.60-4.401.83M1.83M
2019-05-01-10.40—921.00K—
2019-02-27-4.00-4.404.52M3.32M
2018-11-08-2.40-6.003.38M6.75M
2018-08-03-11.60-10.002.47M1.99M
2018-05-15-12.00-14.002.06M2.34M
2018-02-27-17.60-16.40233.00K222.41K
2017-11-01-15.20-16.0015.00K15.79K
2017-08-02-16.40-18.4013.00K13.63K
2017-05-03-17.60-18.4030.00K30.00K
2017-02-27-16.80-5.6038.00K25.33K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-26BAKER BROS. ADVISORS LPBuy6.00K$35.08210.48K
2026-06-26SPIEGELMAN DANIEL KBuy6.00K$35.08210.48K
2026-06-26AKKARAJU SRINIVASBuy6.00K$35.08210.48K
2026-06-26Al-Marzooqi FahedBuy6.00K$35.08210.48K
2026-06-26Phillips Anne M.Buy6.00K$35.08210.48K
2026-02-17Tung Michael StephenBuy44.97K$36.921.66M
2026-02-17SEKHRI PAUL JBuy140.00K$36.925.17M
2025-09-22AKKARAJU SRINIVASBuy983.21K$22.7122.33M
2025-09-22AKKARAJU SRINIVASBuy877.21K$0.018.77K
2025-09-22AKKARAJU SRINIVASBuy106.00K$15.271.62M
2025-09-03AKKARAJU SRINIVASBuy655.52K$0.016.56K
2025-09-03AKKARAJU SRINIVASBuy655.52K$22.7114.89M
2025-09-03BAKER BROS. ADVISORS LPBuy2.35M$0.0123.54K
2025-09-03BAKER BROS. ADVISORS LPBuy2.40M——
2025-09-03BAKER BROS. ADVISORS LPBuy217.14K$0.012.17K
2025-09-03BAKER BROS. ADVISORS LPBuy221.45K——
2025-09-03BAKER BROS. ADVISORS LPBuy46.69K$15.27712.75K
2025-09-03BAKER BROS. ADVISORS LPBuy4.31K$15.2765.76K
2025-06-10BAKER BROS. ADVISORS LPBuy4.00K$16.5966.36K
2025-06-10SPIEGELMAN DANIEL KBuy4.00K$16.5966.36K
2025-06-10AKKARAJU SRINIVASBuy4.00K$16.5966.36K
2025-06-10Phillips Anne M.Buy4.00K$16.5966.36K
2025-06-10Al-Marzooqi FahedBuy4.00K$16.5966.36K
2025-05-19Tung Michael StephenBuy45.00K$21.25956.25K
2025-05-19Tung Michael StephenOther0——
2025-04-11Brown Barry K.Other0——
2025-04-11Brown Barry K.Other500$82.8041.40K
2025-04-11Brown Barry K.Other228$232.4052.99K
2025-04-11Brown Barry K.Other250$368.8092.20K
2025-04-11Brown Barry K.Other10.10K$11.81119.30K
2025-04-11Brown Barry K.Other250$87.2021.80K
2025-04-11Brown Barry K.Other10.00K$19.66196.60K
2025-04-11Brown Barry K.Other5.00K$28.48142.40K
2025-03-01SEKHRI PAUL JBuy108.00K$19.662.12M
2024-11-18SEKHRI PAUL JBuy1.84K$16.9631.27K
2024-11-15SEKHRI PAUL JBuy1.78K$16.8830.01K
2024-11-15SEKHRI PAUL JBuy1.38K$16.3522.53K
2024-06-25AKKARAJU SRINIVASBuy983$17.2216.93K
2024-06-25AKKARAJU SRINIVASBuy2.25K$17.2238.74K
2024-06-25BAKER BROS. ADVISORS LPBuy6.00K$17.22103.32K
2024-06-25BAKER BROS. ADVISORS LPBuy983$17.2216.93K
2024-06-25SPIEGELMAN DANIEL KBuy6.00K$17.22103.32K
2024-06-25Al-Marzooqi FahedBuy3.00K$17.2251.66K
2024-06-25Phillips Anne M.Buy860$17.2214.81K
2024-06-25Phillips Anne M.Buy2.25K$17.2238.74K
2024-06-11SPIEGELMAN DANIEL KOther0——
2024-03-13Phillips Anne M.Buy3.75K$16.0460.15K
2024-03-13Phillips Anne M.Other0——
2024-03-05Samsara BioCapital GP, LLCBuy58.88K$0.01589
2024-03-05Samsara BioCapital GP, LLCSell58.84K$0.01588
2024-03-05AKKARAJU SRINIVASBuy58.88K$0.01589
2024-03-05AKKARAJU SRINIVASSell58.84K$0.01588
2024-03-05BAKER BROS. ADVISORS LPBuy52.92K$0.01529
2024-03-05BAKER BROS. ADVISORS LPBuy4.78K$0.0148
2024-03-05BAKER BROS. ADVISORS LPSell52.88K——
2024-03-05BAKER BROS. ADVISORS LPSell4.78K——
2024-02-27AKKARAJU SRINIVASBuy3.75K$8.5031.88K
2024-02-27Al-Marzooqi FahedBuy4.05K$11.8147.89K
2024-02-27SEKHRI PAUL JBuy89.21K$11.811.05M
2024-02-27Tuch Steven L.Buy62.16K$11.81734.10K
2024-02-27BAKER BROS. ADVISORS LPOther0——
2024-02-27BAKER BROS. ADVISORS LPOther0——
2024-02-27BAKER BROS. ADVISORS LPOther2.77M$0.0127.70K
2024-02-27Cheong RaymondOther0——
2024-02-27Samsara BioCapital GP, LLCOther0——
2024-02-27Samsara BioCapital GP, LLCOther833.69K$0.018.34K
2024-02-27AKKARAJU SRINIVASBuy833.69K$0.018.34K
2024-02-27AKKARAJU SRINIVASBuy224.73K$11.812.65M
2024-02-23AKKARAJU SRINIVASOther0——
2023-06-19FRY JOHN ABuy75.00K$0.8060.00K
2023-06-19Al-Marzooqi FahedBuy75.00K$0.8060.00K
2023-06-19Harjivan ChandreshBuy75.00K$0.8060.00K
2023-06-19Harris Keith R.Buy75.00K$0.8060.00K
2023-06-19Weiner Howard L.Buy75.00K$0.8060.00K
2023-06-19KOZLOV HERSHBuy75.00K$0.8060.00K
2022-12-12Tuch Steven L.Buy500.00K——
2022-12-08Tuch Steven L.Other0——
2022-12-08Tuch Steven L.Other———
2022-11-29FRY JOHN ABuy40.46K$0.8333.77K
2022-11-28FRY JOHN ABuy20.54K$0.8316.97K
2022-08-17Isaacsohn JonathanOther0——
2022-08-17Isaacsohn JonathanBuy50.00K——
2022-08-09Isaacsohn JonathanOther0——
2022-08-01SEKHRI PAUL JSell2.20M$0.791.74M
2022-07-13Harris Keith R.Buy25.00K$0.6917.25K
2022-07-13Harris Keith R.Buy25.00K——
2022-07-13Al-Marzooqi FahedBuy25.00K——
2022-07-11Harris Keith R.Other0——
2022-07-01Weiner Howard L.Buy105.13K$0.7275.69K
2022-07-01Weiner Howard L.Buy105.13K——
2022-07-01KOZLOV HERSHBuy105.13K$0.7275.69K
2022-07-01KOZLOV HERSHBuy105.13K——
2022-07-01Harjivan ChandreshBuy25.00K——
2022-07-01FRY JOHN ABuy137.08K——
2022-06-01Harjivan ChandreshOther0——
2022-05-31Al-Nahyan Tahnoon Bin Zayed S.Other0——
2022-05-31G42 Investments AI Holdings RSC Ltd.Sell0——
2022-03-29Brown Barry K.Sell0——
2022-03-29Brown Barry K.Sell10.00K$2.1821.80K
2022-03-29Brown Barry K.Sell20.00K$2.0741.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 44, holders +9 vs prior quarter. Ownership 12.95%.

HolderSharesChangeChange %Value
SAMSARA BIOCAPITAL, LLC298.50K00.00%11.24M
MILLENNIUM MANAGEMENT LLC269.87K63.59K+30.82%10.16M
FMR LLC260.39K00.00%9.80M
SIREN, L.L.C.163.00K00.00%6.14M
BAKER BROS. ADVISORS LP148.31K00.00%5.58M
VANGUARD CAPITAL MANAGEMENT LLC94.46K-14.46K-13.27%3.56M
TRAILS EDGE CAPITAL PARTNERS, LP85.19K-54.39K-38.96%3.21M
AISLING CAPITAL MANAGEMENT LP50.00K50.00KNew1.88M
MARSHALL WACE, LLP39.56K26.17K+195.47%1.49M
GEODE CAPITAL MANAGEMENT, LLC32.47K-416-1.26%1.22M
RENAISSANCE TECHNOLOGIES LLC17.45K17.45KNew657.14K
VANGUARD FIDUCIARY TRUST CO16.24K113+0.70%611.40K
BLACKROCK, INC.14.73K2.13K+16.89%554.62K
JANE STREET GROUP, LLC13.70K13.70KNew515.92K
STATE STREET CORP12.27K1.60K+15.00%461.81K
TWO SIGMA INVESTMENTS, LP11.49K11.49KNew432.45K
VERDAD ADVISERS, LP9.00K9.00KNew338.70K
INTEGRATED QUANTITATIVE INVESTMENTS LLC8.21K8.21KNew309.11K
SUSQUEHANNA INTERNATIONAL GROUP, LLP8.02K8.02KNew302.07K
QUADRATURE CAPITAL LTD6.30K6.30KNew237.38K
TREXQUANT INVESTMENT LP6.24K6.24KNew234.94K
NORTHERN TRUST CORP6.12K-11.93K-66.08%230.53K
PATHSTONE HOLDINGS, LLC6.07K00.00%228.66K
POINT72 ASSET MANAGEMENT, L.P.5.95K5.95KNew223.91K
HRT FINANCIAL LP5.92K5.92KNew223.00K

Earnings and financials

vTv Therapeutics Inc. (VTVT) trades at $25.61, with a market cap of $101.28M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

vTv Therapeutics (VTVT) Financials: Revenue & Earnings

VTVT$25.61-0.10 -0.41%

$101.28M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History